Dynamic regulation of Drosophila nuclear receptor activity in vivo.
Nuclear receptors are a large family of transcription factors that play major roles in development, metamorphosis, metabolism and disease. To determine how, where and when nuclear receptors are regulated by small chemical ligands and/or protein partners, we have used a 'ligand sensor' system to visualize spatial activity patterns for each of the 18 Drosophila nuclear receptors in live developing animals. Transgenic lines were established that express the ligand binding domain of each nuclear receptor fused to the DNA-binding domain of yeast GAL4. When combined with a GAL4-responsive reporter gene, the fusion proteins show tissue- and stage-specific patterns of activation. We show that these responses accurately reflect the presence of endogenous and exogenously added hormone, and that they can be modulated by nuclear receptor partner proteins. The amnioserosa, yolk, midgut and fat body, which play major roles in lipid storage, metabolism and developmental timing, were identified as frequent sites of nuclear receptor activity. We also see dynamic changes in activation that are indicative of sweeping changes in ligand and/or co-factor production. The screening of a small compound library using this system identified the angular psoralen angelicin and the insect growth regulator fenoxycarb as activators of the Ultraspiracle (USP) ligand-binding domain. These results demonstrate the utility of this system for the functional dissection of nuclear receptor pathways and for the development of new receptor agonists and antagonists that can be used to modulate metabolism and disease and to develop more effective means of insect control.
Palanker
Laura
L
Department of Human Genetics, Howard Hughes Medical Institute, University of Utah School of Medicine, Salt Lake City, UT 84112-5331, USA.
Necakov
Aleksandar S
AS
Sampson
Heidi M
HM
Ni
Ruoyu
R
Hu
Chun
C
Thummel
Carl S
CS
Krause
Henry M
HM
D000818:Animals; D030801:Animals, Genetically Modified; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D004330:Drosophila / Q000196:embryology / Q000235:genetics* / Q000378:metabolism; D029721:Drosophila Proteins / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D004789:Enzyme Activation / Q000187:drug effects; D011564:Furocoumarins / Q000494:pharmacology; D051717:Fushi Tarazu Transcription Factors / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000235:genetics; D006728:Hormones / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology; D008024:Ligands; D008954:Models, Biological; D048448:Phenylcarbamates / Q000494:pharmacology; D011485:Protein Binding / Q000235:genetics; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D015533:Transcriptional Activation / Q000235:genetics
D004268:DNA-Binding Proteins; D029721:Drosophila Proteins; D011564:Furocoumarins; D051717:Fushi Tarazu Transcription Factors; D006728:Hormones; D008024:Ligands; D048448:Phenylcarbamates; D018160:Receptors, Cytoplasmic and Nuclear; D011993:Recombinant Fusion Proteins; C011659:angelicin; C052034:fenoxycarb